HighTower Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,804
Closed -$23.8K – 3884
2026
Q2
$23.8K Buy
1,804
+984
+120% +$22K ﹤0.01% 3765
2026
Q1
$21.6K Sell
820
-11
-1% -$1.38K ﹤0.01% 3754
2025
Q4
$206K Buy
831
+587
+241% +$134K ﹤0.01% 3353
2025
Q3
$51.3K Buy
+244
New +$43K ﹤0.01% 3606

Other funds holding GOSS

HighTower Advisors's GOSS Position: Q3 2026 in Review

HighTower Advisors sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 1,804 shares — an estimated $23.8K sold.

HighTower Advisors first reported a position in GOSS in Q3 2025 and held it in 4 quarters. The position peaked at $206K in Q4 2025. 76 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • HighTower Advisors reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • HighTower Advisors sold 1,804 Gossamer Bio shares in Q3 2026, an estimated $23.8K.
  • HighTower Advisors first reported a position in Gossamer Bio in Q3 2025 and held it in 4 quarters.
  • HighTower Advisors's Gossamer Bio position peaked at $206K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.